1.Introduction
1.1. Research Methodology
1.2. Research Scope
1.2.1.Analysis by Company
1.2.2.Analysis by Phase
1.2.3.By Molecule Type
1.2.4.By region
2.Disease Overview
2.1.1.Introduction
2.1.2.Classification
2.1.3.Symptoms
2.1.4.Causes
2.1.5.Diagnoses
2.1.6.Treatment
2.1.7.Epidemiology
3.Executive Summary
4.Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
5.Pipeline Analysis/Outlook
5.1. Analysis by Company
5.2. Analysis by Phase
5.2.1.Phase of Development
5.2.1.1.Introduction
5.2.1.1.1.Drug profiling
•Drug Name
•Generic Name
•Synonyms
•Company
•Collaborator
•Route of administration
•Target
•Mechanism of Action
•Technology
•Molecule type
•CAS Number
•Weight
•Chemical Formula
•IUPAC name
•ATC code
5.2.1.1.2.Strategic Developments
5.2.1.1.3.Clinical trials
5.2.1.1.4.Clinical trial results
5.2.1.1.5.Patents
5.2.1.1.6.Technology
5.2.2.Comparative Analysis for Trials by Phase (Pie, Bar graph)
5.3. By Molecule type
5.4. Analysis by Region
6.Company profiling
6.1. La Jolla Pharmaceutical Company
6.1.1.Introduction
6.1.2.Financials
6.1.3.Products and Services
6.1.4.SWOT
6.2. Genzyme Corporation
6.2.1.Introduction
6.2.2. Financials
6.2.3. Products and Services
6.2.4. SWOT
6.3. DisperSol Technologies LLC
6.3.1.Introduction
6.3.2. Financials
6.3.3. Products and Services
6.3.4. SWOT
6.4. Vifor Pharma Management Ltd.
6.4.1.Introduction
6.4.2. Financials
6.4.3. Products and Services
6.4.4. SWOT
6.5. Ionis Pharmaceuticals, Inc.
6.5.1.Introduction
6.5.2.Financials
6.5.3. Products and Services
6.5.4. SWOT
6.6. Silence Therapeutics
6.6.1.Introduction
6.6.2. Financials
6.6.3. Products and Services
6.6.4. SWOT
6.7. Protagonist Therapeutics, Inc.
6.7.1.Introduction
6.7.2. Financials
6.7.3. Products and Services
6.7.4. SWOT
6.8. Alnylam Pharmaceuticals
6.8.1.Introduction
6.8.2. Financials
6.8.3. Products and Services
6.8.4. SWOT
6.9. Shire Plc
6.9.1.Introduction
6.9.2. Financials
6.9.3. Products and Services
6.9.4. SWOT
6.10. Sideris Pharmaceuticals, Inc.
6.10.1.Introduction
6.10.2. Financials
6.10.3.Products and Services
6.10.4.SWOT
6.11. Celgene Corporation
6.11.1.Introduction
6.11.2. Financials
6.11.3. Products and Services
6.11.4. SWOT
List of Tables
List of Figures